![Cannabinoid stock image](https://assets.obj.ca/2022/10/Drug-stock-image-300x200.webp)
Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored